Koninklijke Philips N.V. reports health technology developments across Diagnosis & Treatment, Connected Care and Personal Health. News from Royal Philips commonly covers order intake and comparable sales trends; product launches and regulatory clearances for imaging, image-guided therapy and AI software; and governance actions from its Annual General Meeting. Recent product themes include CT platforms such as Rembra and Spectral CT Verida, interventional guidance tools such as DeviceGuide and IntraSight Plus, and the Bridge Plus Occlusion Balloon for lead extraction procedures.
The company’s updates also address hospital monitoring, informatics, ultrasound, oral health and personal-care lines. Coverage reflects Philips’ role as a Netherlands-based global health technology company with securities traded on NYSE under PHG and on Euronext Amsterdam under PHIA.
Royal Philips (PHG) published Norelco OneBlade research finding that gaming characters inspire real-world appearance choices among surveyed U.S. male gamers. The research found that 80% of U.S. male gamers ages 18–45 have taken appearance inspiration from gaming avatars or characters, while 51% wish they looked more like their avatar.
Among the findings, 93% believe greater grooming effort would improve their confidence, and 75% report at least one barrier to putting more effort into their appearance. Cost was cited by 30%, lack of priority by 27%, insufficient time by 24% and not knowing where to start by 21%. The announcement pairs the survey with promotion of OneBlade grooming tools.
Royal Philips (PHG) highlighted plans to strengthen its cardiovascular informatics portfolio following its acquisition of MediReport, ahead of TCT 2026.
Philips expects MediReport’s reporting and workflow capabilities to complement its existing systems and support its longer-term direction toward cloud-ready, AI-enabled cardiovascular care. MediReport 360 supports structured documentation and real-time reporting before, during and after procedures. It allows clinical information to be captured once and reused for reports, coding, registries and follow-up.
MediReport’s technologies support cloud and on-premises deployment and interfaces with imaging, hemodynamic and hospital IT systems. The expected enhancement would build on Philips’ existing cardiovascular image management, ultrasound reporting and catheterization-lab information tools.
Royal Philips (NYSE: PHG) launched EXIT-CVD, a five-year cardiovascular research project co-led with University Medical Center Groningen. The consortium brings together 42 partners across 17 countries and plans 22 clinical studies involving more than 14,000 patients across Europe. Enrollment for the first studies will begin in October 2026. The project has a total budget of EUR 27.6 million, co-funded by the European Union Innovative Health Initiative and industry partners.
The consortium aims to prevent cardiovascular disease, reverse its progression or halt progression in advanced stages through earlier detection and personalized interventions. Research includes digital monitoring, cardiac imaging and remote heart failure monitoring. Interventions will be co-created with patients and designed to address socioeconomic, sex- and gender-related and digital access gaps.
Royal Philips (PHG) has formed the Philips Sonicare Global Clinical Advisory Board to advise its oral healthcare business.
The board comprises 12 international dental experts spanning clinical practice, research, education, behavior change and digital dentistry. Philips intends the board to provide guidance on emerging trends, support science-led product development and contribute to clinical exploration. The collaboration is designed for ongoing exchange with external experts and to incorporate dental professionals’ perspectives into the oral healthcare product roadmap.
Royal Philips (PHG) has made its Sonicare Next-Generation DiamondClean 9900 Prestige toothbrush available on Amazon at a price of $379.99. Unveiled in July 2026, the model provides brushing guidance directly on its handle without requiring an app. Its 12-segment mouth map shows cleaned areas and missed spots, while a light ring provides feedback on coverage, pressure and scrubbing patterns.
The 9900 Prestige offers eight modes and three intensity settings, with pressure sensing that automatically adjusts intensity. The Next-Generation DiamondClean 8500 is also available on Amazon for $249.99, offering six modes and three intensity settings. Both models include a rechargeable travel case and charging glass, and use paper-based packaging.
Philips (PHG) and Southwest Mississippi Regional Medical Center (SMRMC) announced the installation of the first Philips Rembra CT system for acute and high-demand imaging environments in the United States.
The FDA 510(k)-cleared Rembra CT is designed to accelerate scanning and image reconstruction, potentially reducing time patients spend on the table and supporting timely decisions in emergency and trauma care. Throughput testing indicates the system can support up to 270 patient exams per day over a 16-hour day, helping manage growing imaging volumes. With an 85 cm bore, described as largest-in-class, and AI-enabled workflows, the system aims to improve access, positioning and workflow efficiency, expanding advanced diagnostic services for patients in southwest Mississippi.
Royal Philips (PHG) reports that two Philips-led public-private research projects, SYMPHONY and AI FORSchung, have received 2026 ITEA Awards of Excellence for AI-enabled healthcare innovation.
SYMPHONY earned the award for “Exceptional Excellence” after creating a reusable, vendor-neutral reference architecture and demonstrating connected healthcare ecosystems in prostate cancer, aortic aneurysm, atrial fibrillation and multiple sclerosis with clinical partners including Leiden University Medical Center, Amsterdam University Medical Center and Karolinska University Hospital. Philips technology from SYMPHONY to automatically segment and measure vascular structures in medical images has FDA clearance and CE marking, and is available in AV Vascular within the Philips AV Cardiovascular Suite.
AI FORSchung received the innovation award for AI methods that compress Fiber Optic RealShape sensing data more than 20 times while maintaining performance in evaluated datasets.
Royal Philips (PHG) announced a new Philips OneBlade and Red Bull project featuring Red Bull athlete Marco Waltenspiel performing what is described as a world-first wingsuit hot-air balloon slalom over Cappadocia, Turkey.
Waltenspiel jumped from 2,800 meters and flew between seven hot-air balloons at speeds up to 200 km/h, with fellow athlete Marco Fürst filming the flight. The collaboration is presented as a celebration of individuality, self-expression and personal style, linking Waltenspiel’s distinctive moustache and appearance to the Philips OneBlade brand positioning.
Royal Philips (PHG) has launched the Philips Lumea IPL 9900 Pro, described as the first at-home IPL hair removal device with real-time audio feedback and motion guidance.
The device pairs with the Lumea IPL app to track movements and provide live audio and visual coaching during treatment. Philips reports more than 90% hair reduction on legs after three treatments and up to five years of smooth-feeling skin with monthly touch-ups, based on consumer perception data. The Lumea IPL 9900 Pro uses SenseIQ Pro sensor technology to detect skin tone and guide light settings, and it is FDA-cleared. It is available on Amazon’s U.S. store at an MSRP of $699.95 and includes an extended five-year warranty with product registration.
Royal Philips (PHG) introduced the FDA 510(k) cleared and CE marked eV14-2v transvaginal ultrasound transducer, expanding its obstetrics and gynecology portfolio with a single, lightweight probe for a broad range of gynecology and early obstetrics exams.
The eV14-2v is designed to reduce transducer changes by combining enhanced penetration, improved resolution, and a wider field of view. Compared to Philips’ 3D9-3v transducer, it offers a 41.7% increase in penetration, 10% higher 2D resolution, a 15.8% wider field of view, and a 22% lighter design [1]. Built on PureWave crystal technology, it supports detailed visualization for infertility and pelvic pain evaluation and aids detection of fetal abnormalities, with the ability to delineate fetal cardiac chambers from around 13 weeks [2].
The eV14-2v integrates with Philips Collaboration Live for real-time remote consultation, potentially improving access to specialty care in underserved communities. It will be showcased alongside Philips’ Alturion, EPIQ Elite, Lumify, and Flash ultrasound systems at the ISUOG 2026 World Congress.